Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
Recruiting now · Not applicable
Conditions studied: Ovarian Cancer
In brief
The "Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation" study is open to a subset of patients with disorders of sex development (DSD) which is associated with the risk of malignancy and a high risk of infertility or sterility. For these patients, experimental gonadal tissue cryopreservation is the only fertility preservation option available. The overall objective of this study is to determine the safety and efficacy of gonadal tissue cryopreservation as a method of preserving fertility and/or restoring hormonal function in patients with gonadal dysgenesis who are at risk of decreased fertility potential or malignancy.
Key facts
- Study ID
- NCT06518746
- Run by
- University of Colorado, Denver
- People needed
- 50
- Starts
- 2021-08-16
- Expected to finish
- 2031-06-30
- Last updated by the study team
- 2025-09-18
Who can join
Age: any, up to 30. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- < 30 years of age
- Individuals diagnosed with a disorder of sex development who have any risk for malignancy in their gonadal tissue and will have their gonads removed for a clinical indication
- Individuals diagnosed with a disorder of sex development who are at risk of primary ovarian insufficiency (POI) due to an underlying genetic condition
You may not qualify if…
- Pregnancy
- Patients likely to retain inherent fertility and reproductive function
- Patients deemed high risk for perioperative complications
- Patients 7-17 years of age unable to provide assent (i.e. significant psychiatric problems/cognitive delay)
- Patients 18 and older unable to provide consent (i.e. significant psychiatric problems/cognitive delay)
Where it is running
- University of Colorado — Aurora, Colorado, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.